Cancer medicines

Fulvestrant

Fulvestrant

An injectable hormone therapy that degrades estrogen receptors.

Sources checked · Introductory guide

On this page

How it works

A SERD that binds estrogen receptors, blocks signaling and promotes receptor loss.[4]

Where it is used

Used alone or with targeted medicines in selected hormone receptor-positive advanced breast cancers.[1]

Key safety points

Disclose anticoagulants, bleeding problems and liver disease. Report leg pain, numbness or weakness after injection promptly.[2]

Questions for your care team

  • Which targeted medicine is paired with it, and is ovarian suppression needed?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Fulvestrant (opens in a new tab)
  2. MedlinePlus · Fulvestrant (opens in a new tab)
  3. NCI Drug Dictionary · Fulvestrant (opens in a new tab)
  4. NCI · Hormone Therapy for Breast Cancer (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Fulvestrant | Cancer Encyclopedia | My Chemo Diary